Astrazeneca Plc (AZN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AZN Annual Balance Sheets →
This page allows investors to track Astrazeneca Plc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents5,711.00
Current Tax Assets Current1,158.00
Cash & Short-term Investments6,869.00
Accounts receivable10,237.00
Inventories6,557.00
Other Current Assets15,297.00
Total Current Assets28,723.00
Equipment/Property/Plant Net12,962.00
Goodwill net21,242.00
Intangible Assets37,846.00
Deferred Tax Assets5,819.00
Other Assets, Noncurrent0.00
Total Assets114,074.00
Liabilities
Accounts Payable25,280.00
Current Tax Liabilities1,784.00
Longterm Borrowings24,715.00
Current Provisions686.00
Total Current Liabilities30,617.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI3,500.00
Noncurrent Provisions9,390.00
Total Liabilities65,355.00
Stockholders' Equity
Other Equity48,711.00
Common Stockholder's Equity48,711.00
Total Stockholder's Equity48,719.00
Liabilities & Stockholder's Equity114,074.00
4 historic quarters locked

Sign in to unlock the full Astrazeneca Plc balance sheet history.

About Astrazeneca Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-067039

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.